Additionally, the correlations between ADH1B and tumor-infiltrating immune cells (TIICs) and immune checkpoints in ovarian cancer were deeply studied for an underlying immunotherapy target and ready-made targeted drugs. The gene discussed is ADH1B; the disease is ovarian carcinoma.